| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
NK3201ChymaseMast cellsTryptaseCarboxypeptidase ARAAS (Angiotensin converting enzyme1)FibrosisRAAS (Renin angiotensin system)| 1 | 2003 | Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. | 
| + | - | nl | Cardiovasc Drug Rev 21(3):185-98 (2003) |
| 2 | 2002 | Effect of chymase inhibitor on vascular proliferation. |
| + | - | nl | Jpn J Pharmacol 90(3):223-7 (2002) |
| 3 | 2004 | Vascular chymase: pathophysiological role and therapeutic potential of inhibition. |
| + | - | nl | Cardiovasc Res 61(4):653-62 (2004) |
| 4 | 2010 | Mast cell proteases: multifaceted regulators of inflammatory disease. |
| + | - | nl | Blood 115(24):4981-90 (2010) |
| 5 | 2006 | Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. |
| + | - | nl | J Pharmacol Sci 100(5):391-7 (2006) |
| 6 | 2010 | New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage. |
| + | - | nl | J Pharmacol Sci 113(4):301-9 (2010) |
| 7 | 2010 | Chymase: the other ACE? |
| + | - | nl | Am J Physiol Renal Physiol 298(1):F35-6 (2010) Lorenz JN |
